Wien | Vollzeit | ab Herbst | EY-Parthenon Dein Team & Umfeld Unser rund 90-köpfiges Strategy & Execution-Team unter der Leitung von Klaus Haberfehlner begleitet Unternehmen bei Strategie-, Transformations- und Transaktionsvorhaben. Im Fokus stehen Themen wie Unternehmensstrategie, Deal
Wien | Vollzeit | ab Herbst | EY-Parthenon Dein Team & Umfeld Unser rund 90-köpfiges Strategy & Execution-Team unter der Leitung von Klaus Haberfehlner begleitet Unternehmen bei Strategie-, Transformations- und Transaktionsvorhaben. Im Fokus stehen Themen wie Unternehmensstrategie, Deal
At Machine Learning Reply Austria we strive to work on leading-edge data science projects with our clients for which we are seeking Data Frameworks consultants with a strong economics and IT background to support on the
Wien | Vollzeit | ab Herbst 2026 | EY-Parthenon Bewerbungsfrist: 31.07.2026 Cast Study Assessmentphase: August / September 2026 Dein Team & Umfeld Unser rund 90-köpfiges Strategy & Execution-Team unter der Leitung von Klaus Haberfehlner begleitet Unternehmen bei Strategie-,
Become part of a vital chain and contribute to our common goal of making people’s lives better. Octapharma is one of the largest human protein manufacturers in the world, developing and producing medicines sourced from human
Are you at your best when business needs meet smart technology – and meaningful progress happens? Join us in shaping a transparent, value-driven digitalization portfolio that supports the continued transformation of Sandvik Powder Solutions. Why Sandvik?
About BJAK The original mission of BJAK is we believe people deserve smarter ways to plan, save and grow their money. This is the origin of our name. Started in 2019, we built the first mobile-first,
About BJAK The original mission of BJAK is we believe people deserve smarter ways to plan, save and grow their money. This is the origin of our name. Started in 2019, we built the first mobile-first,
About BJAK The original mission of BJAK is we believe people deserve smarter ways to plan, save and grow their money. This is the origin of our name. Started in 2019, we built the first mobile-first,
About BJAK The original mission of BJAK is we believe people deserve smarter ways to plan, save and grow their money. This is the origin of our name. Started in 2019, we built the first mobile-first,
About Allocator One Allocator One Group is a global investing and operating platform reshaping how institutional capital reaches private markets. We are one of the most active backers of emerging fund managers and have visibility on
About KIRA Our mission is to make money smart, reliable and within reach for everyone. In 2019, we built the first mobile-first, insurance platform, enabling insurance to be accessible online by millions in the region. Today,
About KIRA Our mission is to make money smart, reliable and within reach for everyone. In 2019, we built the first mobile-first, insurance platform, enabling insurance to be accessible online by millions in the region. Today,
About KIRA Our mission is to make money smart, reliable and within reach for everyone. In 2019, we built the first mobile-first, insurance platform, enabling insurance to be accessible online by millions in the region. Today,
About KIRA Our mission is to make money smart, reliable and within reach for everyone. In 2019, we built the first mobile-first, insurance platform, enabling insurance to be accessible online by millions in the region. Today,
SummaryThe people here at Apple don’t just create products — they create the kind of wonder that’s revolutionized entire industries. It’s the diversity of those people and their ideas that inspires the innovation that runs through
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Company Description You will be responsible for the end-to-end development and product lifecycle management of our Point of Sale (POS) and Trade Marketing Materials. These are physical marketing materials used to showcase and sell our products
By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda’s Privacy Notice and Terms
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)